Sequence and structural determinants of Cu, Zn superoxide dismutase aggregation

Proteins: Structure, Function and Genetics

Volumn 61, Issue 3, 2005, Pages 617-632

  Khare, Sagar D ^a   Wilcox, Kyle C ^a   Gong, Peng ^a   Dokholyan, Nikolay V ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Cu, Zn superoxide dismutase; Domain swapping; Molecular dynamics simulation; Protein aggregation; Protein misfolding

Indexed keywords

AMYLOID; COPPER ZINC SUPEROXIDE DISMUTASE;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COMPUTER MODEL; MOLECULAR DYNAMICS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; SIMULATION; STRUCTURE ANALYSIS;

AMYLOID; COPPER; DIMERIZATION; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY; SEQUENCE ANALYSIS, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE; THERMODYNAMICS; ZINC;

EID: 27544443962     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.20629     Document Type: Article

References (71)

1. Dobson CM. Protein folding and misfolding. Nature 2003;426:884-890.
2. Dobson CM. Protein chemistry. In the footsteps of alchemists. Science 2004;304:1259-1262.
3. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806-819.
4. Reches M, Porat Y, Gazit E. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem 2002;277:35475-35480.
5. Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H, Kapurniotu A. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 2000;295:1055-1071.
6. Thirumalai D, Klimov DK, Dima RI. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol 2003;13:146-159.
7. Villegas V, Zurdo J, Filimonov W, Aviles FX, Dobson CM, Serrano L. Protein engineering as a strategy to avoid formation of amyloid fibrils. Protein Sci 2000;9:1700-1708.
8. Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson CM, Aviles FX, Serrano L. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA 2004;101:7258-7263.
9. Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D. An amyloid-forming segment of beta 2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 2004;101: 10584-10589.
10. Tycko R. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol 2004;14:96-103.
11. Benzinger TLS, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci USA 1998;95:13407-13412.
12. Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 2005;102:315-320.
13. Gordon DJ, Balbach JJ, Tycko R, Meredith SC. Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. Biophys J 2004;86:428-434.
14. de la Paz ML, Serrano L. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 2004;101:87-92.
15. Rochet JC, Lansbury PT. Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 2000;10:60-68.
16. Richardson JS, Richardson DC. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 2002;99:2754-2759.
17. Tainer JA, Getzoff ED, Beem KM, Richardson JS, Richardson DC. Determination and analysis of the 2A structure of copper, zinc superoxide-dismutase. J Mol Biol 1982;160:181-217.
18. Rodriguez JA, Valentine JS, Eggers DK, Roe JA, Tiwari A, Brown RH Jr, Hayward LJ. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J Biol Chem 2002;277:15932-15937.
19. Lindberg MJ, Tibell L, Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc Natl Acad Sci USA 2002;99:16607-16612.
20. Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2000;97:12571-12576.
21. Khare SD, Caplow M, Dokholyan NV. Determination of the rate and equilibrium constants for a multi-step reaction for aggregation of superoxide dismutase in ALS. Proc Natl Acad Sci USA 2004;101:15094-15099.
22. Ray SS, Nowak RJ, Strokovich K, Brown RH Jr, Walz T, Lansbury PT Jr. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry 2004;43:4899-4905.
23. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, Chakrabartty A. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 2004;279:15499-15504.
24. Bennett MJ, Choe S, Eisenberg D. Domain swapping-entangling alliances between proteins. Proc Natl Acad Sci USA 1994;91:3127-3131.
25. Schlunegger MP, Bennett MJ, Eisenberg D. Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. Adv Protein Chem 1997;50:61-122.
26. Liu YS, Gotte G, Libonati M, Eisenberg D. A domain-swapped RNase A dimer with implications for amyloid formation. Nat Struct Biol 2001;8:211-214.
27. Rousseau F, Schymkowitz JWH, Itzhaki LS. The unfolding story of three-dimensional domain swapping. Structure 2003;11:243-251.
28. Liu Y, Eisenberg D. 3D domain swapping: as domains continue to swap. Protein Sci 2002;11:1285-1299.
29. Yang S, Levine H, Onuchic JN. Protein oligomerization through domain swapping: Role of inter-molecular interactions and protein concentration. J Mol Biol. Forthcoming.
30. Yang SC, Cheung MS, Onuchic JN, Levine H. Molecular dynamics simulations on domain swapping. Biophys J 2004;86:267A-268A.
31. Yang SC, Cho SS, Levy Y, Cheung MS, Levine H, Wolynes PG, Onuchic JN. Domain swapping is a consequence of minimal frustration. Proc Natl Acad Sci USA 2004;101:13786-13791.
32. Rousseau F, Schymkowitz JWH, Wilkinson HR, Itzhaki LS. Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues. Proc Natl Acad Sci USA 2001;98:5596-5601.
33. Liu YS, Hart PJ, Schlunegger MP, Eisenberg D. The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1-angstrom resolution. Proc Natl Acad Sci USA 1998;95:3437-3442.
34. Liu YS, Gotte G, Libonati M, Eisenberg D. Structures of the two 3D domain-swapped RNase A trimers. Protein Sci 2002;11:371-380.
35. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001;8:316-320.
36. Go N, Abe H. Noninteracting local-structure model of folding and unfolding transition in globular proteins: I. Formulation. Biopolymers 1981;20:991-1011.
37. Abe H, Go N. Noninteracting local-structure model of folding and unfolding transition in globular proteins: II. Application to two-dimensional lattice proteins. Biopolymers 1981;20:1013-1031.
38. Ding F, Dokholyan NV, Buldyrev SV, Stanley HE, Shakhnovich EI. Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. J Mol Biol 2002;324:851-857.
39. Kishan KVR, Scita G, Wong WT, DiFiore PP, Newcomer ME. The SH3 domain of Eps8 exists as a novel intertwined dimer. Nat Struct Biol 1997;4:739-743.
40. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 1997;273:729-739.
41. Hermans J, Berendsen HJC, Vangunsteren WF, Postma JPM. A consistent empirical potential for water-protein interactions. Biopolymers 1984;23:1513-1518.
42. Vorobjev YN, Almagro JC, Hermans J. Discrimination between native and intentionally misfolded conformations of proteins: ES/IS, a new method for calculating conformational free energy that uses both dynamics simulations with an explicit solvent and an implicit solvent continuum model. Proteins 1998;32:399-413.
43. Urbanc B, Cruz L, Ding F, Sammond D, Khare S, Buldyrev SV, Stanley HE, Dokholyan NV. Molecular dynamics simulations of amyloid beta dimer formation. Biophys J 2004;87:2310-2321.
44. Vorobjev YN, Hermans J. Free energies of protein decoys provide insight into determinants of protein stability. Protein Sci 2001;10: 2498-2506.
45. Khare SD, Ding F, Dokholyan NV. Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis. J Mol Biol 2003;334:515-525.
46. Rubinstein M, Colby RH. Polymer physics. New York: Oxford University Press; 2003.
47. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 2004;22:1302-1306.
48. Dokholyan NV, Li L, Ding F, Shakhnovich EI. Topological determinants of protein folding. Proc Natl Acad Sci USA 2002;99:8637-8641.
49. Dokholyan NV, Borreguero JM, Buldyrev SV, Ding F, Stanley HE, Shakhnovich EI. Identifying importance of amino acids for protein folding from crystal structures. Macromol Crystallogr D 2003;374: 618-640.
50. Pande VS, Grosberg AY, Tanaka T. Heteropolymer freezing and design: towards physical models of protein folding. Rev Modern Phys 2000;72:259-314.
51. Bryngelson JD, Onuchic JN, Socci ND, Wolynes PG. Funnels, pathways, and the energy landscape of protein-folding-a synthesis. Proteins 1995;21:167-195.
52. Shea JE, Onuchic JN, Brooks CL. Molecular dynamics study of the mechanism and thermodynamics of folding of the src-SH3 protein. Abstracts of Papers of the American Chemical Society 2001;221:U406-U407.
53. Plotkin SS, Onuchic JN. Understanding protein folding with energy landscape theory-Part I: Basic concepts. Quart Rev Biophys 2002;35:111-167.
54. Ding F, Dokholyan NV. Simple but predictive protein models. Trends Biotechnol. Forthcoming.
55. Dokholyan NV, Buldyrev SV, Stanley HE, Shakhnovich EI. Discrete molecular dynamics studies of the folding of a protein-like model. Fold Des 1998;3:577-587.
56. Ding F, Borreguero JM, Buldyrey SV, Stanley HE, Dokholyan NV. Mechanism for the alpha-helix to beta-hairpin transition. Proteins 2003;53:220-228.
57. Mei G, Rosato N, Silva N Jr, Rusch R, Gratton E, Savini I, Finazzi-Agro A. Denaturation of human Cu/Zn superoxide-dismutase by guanidine-hydrochloride-a dynamic fluorescence study. Biochemistry 1992;31:7224-7230.
58. Hwang W, Zhang SG, Kamm RD, Karplus M. Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci USA 2004;101:12916-12921.
59. Tcherkasskaya O, Sanders W, Chynwat V, Davidson EA, Orser CS. The role of hydrophobic interactions in amyloidogenesis: example of prion-related polypeptides. J Biomol Struct Dyn 2003;21:353-365.
60. Tycko R. Solid-state nuclear magnetic resonance techniques for structural studies of amyloid fibrils. Methods Enzymol 2001;339: 390-413.
61. Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB, Stanley HE. In silico study of amyloid beta-protein folding and oligomerization. Proc Natl Acad Sci USA 2004;101:17345-17350.
62. Doyle R, Simons K, Qian H, Baker D. Local interactions and the optimization of protein folding. Proteins 1997;29:282-291.
63. Simons KT, Ruczinski I, Kooperberg C, Fox BA, Bystroff C, Baker D. Improved recognition of native-like protein structures using a combination of sequence-dependent and sequence-independent features of proteins. Proteins 1999;34:82-95.
64. Bystroff C, Baker D. Prediction of local structure in proteins using a library of sequence-structure motifs. J Mol Biol 1998;281:565-577.
65. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 2002;16:77-83.
66. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003;424:805-808.
67. Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA 2002;99:16419-16426.
68. Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol 2004;342:345-353.
69. DiDonato M, Craig L, Huff ME, Thayer MM, Cardoso RM, Kassmann CJ, Lo TP, Bruns CK, Powers ET, Kelley JW, Getzoff ED, Tainer JA. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol 2003;332:601-615.
70. Stathopulos PB, Rumfeldt JA, Scholz GA, Irani RA, Frey HE, Hallewell RA, Lepock JR, Meiering EM. Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc Natl Acad Sci USA 2003;100:7021.
71. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, Cashman NR, Kondejewski LH, Chakrabatty A. Oxidation-induced misfolding and agagaregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 2002;277:47551-47556.